The main goals of EuroPE-CDT is to assess the currently applied catheter-directed treatment (CTD) techniques and strategies in pulmonary embolism (PE) patients and to determine the short term efficacy and safety of this invasive procedure.
This is a prospective (and retrospective, if required data are available), non-interventional, multicenter study. We intend to obtain data on basic patients characteristics, pulmonary embolism severity, catheter-directed treatment procedures and short term outcome. We are planning to include approximately 150-200 patients suitable for analysis by the end of 2020. Anonymized data of consecutive PE patients treated with CTD in European centers will be collected in the database.
Study Type
OBSERVATIONAL
Enrollment
145
Department of Internal Medicine & Cardiology with the Centre for Management of Venous Thromboembolic Disease, Medical University of Warsaw
Warsaw, Poland
Survival
Short-time follow-up
Time frame: 30 days after the procedure
Complications
Any procedure-related complications, such as: * local hematoma, * hemoptysis, * pulmonary artery injury, * contrast-induced nephropathy, * renal replacement therapy.
Time frame: During hospitalisation (estimated 10 days)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.